Thiamine Use in Sepsis: B1 for Everyone?

Jacob P Counts, Victor F Rivera, Lauren A Kimmons, G Morgan Jones

Journal: Critical care nursing quarterly 2019;42(3):292-303

PMID: 31135480

Abstract

Every year, sepsis affects nearly 30 million people worldwide, with current annual estimates reporting as many as 6 million deaths. To combat the staggering number of patients who are affected by sepsis, clinicians continue to investigate novel treatment approaches. One treatment approach that has gained interest is the role that vitamins and nutrients play in the body's response to sepsis. Thiamine, in particular, has been studied because of its role in glucose metabolism and lactate production. This review provides a summary of the current literature surrounding the use of thiamine in the treatment of sepsis and describes the function of this essential nutrient in sepsis pathology. We also aim to provide clinicians with the necessary understanding to recognize the potential for thiamine deficiency, as well as detail the role of thiamine supplementation in the treatment of sepsis.

Address: College of Pharmacy (Mr Counts and Dr Kimmons) and Department of Clinical Pharmacy, Neurology and Neurosurgery (Dr Jones), University of Tennessee Health Science Center, Memphis; and Department of Pharmacy, Methodist University Hospital, Memphis, Tennessee (Drs Rivera, Kimmons, and Jones).
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.